On immunohistochemistry, CD31 and CD34 positivity indicates hemangiomas, lymphangiomas, and other benign vascular tumors, and the lymphatic endothelial marker D2‐40 negativity and lymphocyte deficiency help to rule out lymphangiomas [22, 27, 31]. This evidence concerns the gene CD34 and lymphangioma.